|
Delayed
London S.E.
04:18:18 03/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.000 GBX | +5.26% |
|
+5.26% | -47.37% |
| 04:15pm | WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan | AN |
| 27/10 | River Global to go private; Software Circle buy | AN |
| Market Cap | 21.58L 28.96L 25.86L 23.73L 40.46L 27Cr 41.27L 2.83Cr 1.14Cr 14Cr 1.09Cr 1.06Cr 46Cr | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 20.09L 26.96L 24.07L 22.09L 37.67L 26Cr 38.42L 2.64Cr 1.06Cr 13Cr 1.01Cr 99.03L 43Cr | EV / Sales 2024 |
6,18,09,222x | EV / Sales 2025 | 7,61,38,323x |
| Free-Float |
81.3% | Yield 2024 * |
-
| Yield 2025 | - |
| 06/02 | BSF : Proxy Form | PU |
| 06/02 | BSF : Notice of AGM | PU |
| 06/25/06 | BSF : Publication of Prospectus | PU |
| 06/25/06 | BSF : Prospectus | PU |
| 07/25/07 | BSF : Proxy Form | PU |
| 1 day | +5.26% | ||
| 1 week | +5.26% | ||
| Current month | +11.11% | ||
| 1 month | -11.11% | ||
| 3 months | -16.67% | ||
| 6 months | -50.00% | ||
| Current year | -47.37% |
| 1 week | 0.8 |  | 1.08 |
| 1 month | 0.8 | | 1.25 |
| Current year | 0.5 | | 4 |
| 1 year | 0.5 | | 4 |
| 3 years | 0.5 | | 12.45 |
| 5 years | 0.5 | | 23.88 |
| 10 years | 0.5 | | 23.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 62 | 06/06/2022 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 05/12/2025 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 05/08/2021 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/06/24 | Buy | Chief Financial Officer | 500 | 0.0005% | ||
| 18/06/24 | Buy | Chief Financial Officer | 11,798 | 0.0114% | ||
| 18/06/24 | Buy | Chief Financial Officer | 23,500 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.26% | +5.26% | -68.25% | -87.50% | 24.46L | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,25700Cr | |
| -0.97% | +1.60% | +43.25% | +80.09% | 65TCr | |
| -2.05% | +0.73% | +32.47% | +101.62% | 51TCr | |
| -0.19% | -0.60% | +52.83% | +67.17% | 39TCr | |
| -0.78% | +5.51% | +72.55% | +44.25% | 37TCr | |
| +0.71% | +2.83% | +33.09% | +58.89% | 30TCr | |
| -0.04% | +8.20% | +12.21% | +35.09% | 29TCr | |
| -0.12% | +4.68% | +55.97% | +74.59% | 25TCr | |
| -0.21% | +7.34% | +42.19% | +109.69% | 21TCr | |
| Average | +0.37% | +2.97% | +33.98% | +62.70% | 42.27TCr | |
| Weighted average by Cap. | -0.34% | +5.30% | +49.25% | +93.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.35 0.11 0.76 0.31 3.88 0.29 0.28 12.25 | 0.05 0.07 0.06 0.06 0.1 6.71 0.1 0.69 0.28 3.54 0.27 0.26 11.19 |
| Net income | -16.72L -22.44L -20.03L -18.38L -31.35L -21Cr -31.98L -2.2Cr -88.51L -11Cr -84.22L -82.42L -35Cr | -11.14L -14.94L -13.34L -12.24L -20.88L -14Cr -21.29L -1.46Cr -58.94L -7.47Cr -56.08L -54.88L -24Cr |
| Net Debt | -6L -8L -7L -6L -10.49L -7.11Cr -10.7L -73.48L -29.62L -3.75Cr -28.18L -27.58L -12Cr | -1L -2L -2L -2L -3L -1.89Cr -3L -19.57L -8L -99.92L -8L -7L -3.16Cr |
Employees
14
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | GBX 1.000 | +5.26% | 7,42,326 |
| 02/26/02 | GBX 0.9500 | +5.56% | 74,49,597 |
| 30/26/30 | GBX 0.9000 | 0.00% | 15,70,697 |
| 29/26/29 | GBX 0.9000 | -5.26% | 15,79,395 |
| 28/26/28 | GBX 0.9500 | 0.00% | 4,62,575 |
- Stock Market
- Stocks
- BSFA Stock
Select your edition
All financial news and data tailored to specific country editions
